We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Future Endoscopes Could Incorporate Infrared Optical Coherence Tomography

By HospiMedica International staff writers
Posted on 18 Dec 2009
An infrared (IR) laser powered endoscope scans epithelium layer by layer, providing a three-dimensional (3D) image with microscopic resolution. More...


Developed by scientists at the University of Florida (UF, Gainesville, USA), the laser-powered endoscope is based on optical coherence tomography (OCT). The laser beams through the arm of an OCT scope, hits the tissue, and reflects some light back, while the rest scatters; an interferometer measures the reflected light and subtracts the scattered light. Altering the length of the arm alters the depth at which light is directly reflected back, producing images of different layers, which together form 3D imagery of potential tumors forming within tissue. The prototype device uses a micro-electromechanical system (MEMS)-based approach, centered on a tiny, one-by-one-millimeter mirror that can pivot at a rate of 200 Hz with the help of tiny actuators; as infrared light beams down the endoscope, the mirror steers the light back and forth, illuminating a slice of tissue. The reflected light bounces back up the endoscope, and is analyzed and depicted on a screen in real time. The IR laser powered endoscope was described in the December 3, 2009, newsletter of the journal Technology Review.

"Eighty-five percent of cancers originate from the epithelium, which is about two millimeters deep,” said lead researcher Huikai Xie, Ph.D., an associate professor of electrical and computer engineering and director of the UF biophotonics and microsystems laboratory. "If you need to remove the tumor, the surgeons have a hard time determining when to stop. With a real time, high-resolution tool, they will be sure.”

The prototype is still too big to use in humans, as it requires a total diameter of 5 mm to fit all its parts. However, Dr. Xie plans to miniaturize further the design, and is planning to test it in larger animals such as pigs and goats in 2010. He recently started a company, WiOptix (Gainesville, FL, USA), and is seeking funding from the U.S. National Institutes of Health (NIH) to help commercialize the technology.

Related Links:
University of Florida
WiOptix


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.